about
Evaluation of a worksite cervical screening initiative to increase Pap smear uptake in Malaysia: a cluster randomized controlled trial.Prior autoimmune disease and risk of monoclonal gammopathy of undetermined significance and multiple myeloma: a systematic review.How common are myeloproliferative neoplasms? A systematic review and meta-analysis.Reduced risk of pancreatic cancer associated with asthma and nasal allergies.The value of adjuvant radiotherapy on survival and recurrence in triple-negative breast cancer: A systematic review and meta-analysis of 5507 patients.HPV prevalence and type-distribution in cervical cancer and premalignant lesions of the cervix: A population-based study from Northern Ireland.A systems approach identifies time-dependent associations of multimorbidities with pancreatic cancer risk.The effect of warfarin therapy on breast, colorectal, lung, and prostate cancer survival: a population-based cohort study using the Clinical Practice Research Datalink.Do perinatal and early life exposures influence the risk of malignant melanoma? A Northern Ireland birth cohort analysis.Medications that relax the lower oesophageal sphincter and risk of oesophageal cancer: An analysis of two independent population-based databases.Risk of pancreatic cancer associated with family history of cancer and other medical conditions by accounting for smoking among relatives.Structural approaches to knowledge exchange: comparing practices across five centres of excellence in public health.Automated Tumour Recognition and Digital Pathology Scoring Unravels New Role for PD-L1 in Predicting Good Outcome in ER-/HER2+ Breast CancerNon-steroidal anti-inflammatory drug use and cervical cancer risk: a case-control study using the Clinical Practice Research DatalinkPancreatic cancer risk in relation to lifetime smoking patterns, tobacco type, and dose-response relationships
P50
Q37173631-30AE45F0-56ED-4047-BA45-14ABCC779FD2Q38180863-671F89F5-D463-409F-96A1-A6EBAC46976FQ38223791-382EA54E-F7F9-456E-B4A8-B2E7CBF102D8Q38656288-83EAA23C-DC11-45B2-BE02-C2128CA06D5CQ38841869-CA9A6883-6B98-4CF3-B64C-06F211731DA8Q38930783-97C0546D-3762-4ADF-8929-35AA7BC12C2FQ40255128-64C37C74-256A-4AA9-8FEF-0B46255B575DQ41656424-46BCF394-F3A2-40F8-B68B-783BC26FF12EQ44450736-8B5885E9-C9C9-4C6E-84B4-6537AE52C071Q48111463-68BDD86C-82E6-4CF7-9BE5-D08CDBCE7FA4Q50062998-1E224039-D8B9-4698-99B6-A028CA9DF9DEQ52355848-884E4BB2-BDCF-4AFE-B46F-F6601536E453Q60951859-BE5AC387-726D-4E1C-9745-BACDE2B5F194Q85859355-9FC35CCB-A190-4CC0-A6DA-2E2FB5EAD39FQ89685250-0EB5B08A-8CC9-4346-8C5D-4219AF5FE11A
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
M A O'Rorke
@en
M A O'Rorke
@nl
type
label
M A O'Rorke
@en
M A O'Rorke
@nl
prefLabel
M A O'Rorke
@en
M A O'Rorke
@nl
P31
P496
0000-0002-2425-3323